Free Trial

SRAX (SRAX) Competitors

SRAX logo
$0.0006 0.00 (0.00%)
As of 06/11/2026

SRAX vs. BINI, WEJOF, CAUD, BIAFW, and CFFEW

Should you buy SRAX stock or one of its competitors? MarketBeat compares SRAX with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SRAX include Bollinger Innovations (BINI), Wejo Group (WEJOF), Collective Audience (CAUD), bioAffinity Technologies (BIAFW), and CF Acquisition Corp. VIII (CFFEW). These companies are all part of the "business services" industry.

How does SRAX compare to Bollinger Innovations?

Bollinger Innovations (NASDAQ:BINI) and SRAX (NASDAQ:SRAX) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

SRAX has a net margin of 0.00% compared to Bollinger Innovations' net margin of -5,005.77%.

Company Net Margins Return on Equity Return on Assets
Bollinger Innovations-5,005.77% N/A -318.48%
SRAX N/A N/A N/A

Bollinger Innovations has a beta of -1.31, suggesting that its stock price is 231% less volatile than the broader market. Comparatively, SRAX has a beta of 8, suggesting that its stock price is 700% more volatile than the broader market.

11.7% of Bollinger Innovations shares are held by institutional investors. Comparatively, 8.0% of SRAX shares are held by institutional investors. 3.6% of Bollinger Innovations shares are held by insiders. Comparatively, 10.2% of SRAX shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SRAX has higher revenue and earnings than Bollinger Innovations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bollinger Innovations$9.34M0.00-$457.06MN/AN/A
SRAX$29.29M0.00-$31.64M-$0.95N/A

In the previous week, Bollinger Innovations' average media sentiment score of 0.00 equaled SRAX'saverage media sentiment score.

Company Overall Sentiment
Bollinger Innovations Neutral
SRAX Neutral

Summary

SRAX beats Bollinger Innovations on 6 of the 8 factors compared between the two stocks.

How does SRAX compare to Wejo Group?

SRAX (NASDAQ:SRAX) and Wejo Group (NASDAQ:WEJOF) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment and earnings.

In the previous week, SRAX's average media sentiment score of 0.00 equaled Wejo Group'saverage media sentiment score.

Company Overall Sentiment
SRAX Neutral
Wejo Group Neutral

SRAX has a beta of 8, indicating that its stock price is 700% more volatile than the broader market. Comparatively, Wejo Group has a beta of 1.62, indicating that its stock price is 62% more volatile than the broader market.

8.0% of SRAX shares are owned by institutional investors. Comparatively, 3.2% of Wejo Group shares are owned by institutional investors. 10.2% of SRAX shares are owned by insiders. Comparatively, 19.8% of Wejo Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
SRAXN/A N/A N/A
Wejo Group N/A N/A N/A

SRAX has higher revenue and earnings than Wejo Group. SRAX is trading at a lower price-to-earnings ratio than Wejo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SRAX$29.29M0.00-$31.64M-$0.95N/A
Wejo Group$8.40M0.00-$159.25M-$0.26N/A

Summary

SRAX beats Wejo Group on 4 of the 7 factors compared between the two stocks.

How does SRAX compare to Collective Audience?

Collective Audience (NASDAQ:CAUD) and SRAX (NASDAQ:SRAX) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Company Net Margins Return on Equity Return on Assets
Collective AudienceN/A N/A N/A
SRAX N/A N/A N/A

Collective Audience has higher earnings, but lower revenue than SRAX. Collective Audience is trading at a lower price-to-earnings ratio than SRAX, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Collective Audience$12.14M0.00-$4.57M-$0.09N/A
SRAX$29.29M0.00-$31.64M-$0.95N/A

In the previous week, Collective Audience's average media sentiment score of 0.00 equaled SRAX'saverage media sentiment score.

Company Overall Sentiment
Collective Audience Neutral
SRAX Neutral

Collective Audience has a beta of 12.07, indicating that its share price is 1,107% more volatile than the broader market. Comparatively, SRAX has a beta of 8, indicating that its share price is 700% more volatile than the broader market.

60.8% of Collective Audience shares are held by institutional investors. Comparatively, 8.0% of SRAX shares are held by institutional investors. 58.0% of Collective Audience shares are held by company insiders. Comparatively, 10.2% of SRAX shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Collective Audience beats SRAX on 6 of the 8 factors compared between the two stocks.

How does SRAX compare to bioAffinity Technologies?

SRAX (NASDAQ:SRAX) and bioAffinity Technologies (NASDAQ:BIAFW) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

8.0% of SRAX shares are held by institutional investors. 10.2% of SRAX shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, bioAffinity Technologies had 1 more articles in the media than SRAX. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for SRAX. bioAffinity Technologies' average media sentiment score of 1.87 beat SRAX's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
SRAX Neutral
bioAffinity Technologies Very Positive

bioAffinity Technologies has lower revenue, but higher earnings than SRAX.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SRAX$29.29M0.00-$31.64M-$0.95N/A
bioAffinity Technologies$5.61MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
SRAXN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

Summary

SRAX beats bioAffinity Technologies on 3 of the 5 factors compared between the two stocks.

How does SRAX compare to CF Acquisition Corp. VIII?

SRAX (NASDAQ:SRAX) and CF Acquisition Corp. VIII (NASDAQ:CFFEW) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

8.0% of SRAX shares are held by institutional investors. 10.2% of SRAX shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, SRAX's average media sentiment score of 0.00 equaled CF Acquisition Corp. VIII'saverage media sentiment score.

Company Overall Sentiment
SRAX Neutral
CF Acquisition Corp. VIII Neutral

CF Acquisition Corp. VIII has lower revenue, but higher earnings than SRAX.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SRAX$29.29M0.00-$31.64M-$0.95N/A
CF Acquisition Corp. VIIIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
SRAXN/A N/A N/A
CF Acquisition Corp. VIII N/A N/A N/A

Summary

SRAX beats CF Acquisition Corp. VIII on 3 of the 3 factors compared between the two stocks.

Get SRAX News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRAX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRAX vs. The Competition

MetricSRAXAdvertising agencies IndustryBusiness SectorNASDAQ Exchange
Market Cap$18K$284.03M$6.67B$11.98B
Dividend YieldN/A5.98%3.09%5.57%
P/E Ratio0.0015.5428.5824.45
Price / Sales0.0027.66408.84136.74
Price / CashN/A9.3023.2354.62
Price / BookN/A2.205.796.80
Net Income-$31.64M$18.37M$205.40M$337.76M
7 Day PerformanceN/A-6.43%-0.29%2.08%
1 Month PerformanceN/A-2.75%0.04%3.16%
1 Year PerformanceN/A-14.57%33.39%27.78%

SRAX Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRAX
SRAX
N/A$0.00
flat
N/A-98.8%$18K$29.29MN/A130
BINI
Bollinger Innovations
N/A$0.09
+58.6%
N/A-100.0%$45K$9.34MN/A120
WEJOF
Wejo Group
N/A$0.00
flat
N/AN/A$11K$8.40MN/A300
CAUD
Collective Audience
N/A$0.00
flat
N/A-81.8%$10K$12.14MN/A23
BIAFW
bioAffinity Technologies
N/A$0.16
+0.3%
N/A+8.3%$0.00$5.61MN/A10

Related Companies and Tools


This page (NASDAQ:SRAX) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners